donor-derived CD22 CAR T therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for donor-derived CD22 CAR T therapy, covering 2026-03-09 to 2026-03-09. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Tolerability, and Pharmacokinetics of Donor-derived CD19 CAR Therapy Bridged Allo-HSCT and Sequential Donor-derived CD22 CAR Therapy for r/r B-ALL: a Clinical Trial [Phase 1]